Clinical Application Value: Menghini Liver Biopsy Needle Leads To Precise Diagnosis Of Liver Diseases

In the medical needle category, the biopsy needle is the core instrument in the field of minimally invasive diagnosis. Among them, the Menghini Liver Biopsy Needle, with its exclusive adaptability for liver disease diagnosis, has become the preferred tool for clinical liver biopsy, completely changing the diagnostic mode of liver diseases. Since Italian pathologist Giorgio Menghini invented this needle in 1958, after more than six decades of clinical verification, it has been widely used in various levels of medical institutions worldwide due to its core advantages of simplicity, speed and efficiency, and has established an irreplaceable position in the medical needles for liver disease diagnosis.
The liver, as an important metabolic organ in the human body, is vulnerable to various diseases such as hepatitis, fatty liver, liver cirrhosis, benign and malignant tumors, etc. Pathological biopsy is the "gold standard" for diagnosing liver diseases, providing the most direct basis for clinical classification, treatment plan formulation, and prognosis assessment. As early as 1939, Roholm and Iversen pioneered the liver biopsy technique. However, traditional puncture instruments have problems such as incomplete sampling, cumbersome operation, large patient trauma, and high risk of complications, making it difficult to meet the needs of clinical popularization. The emergence of the Menghini liver biopsy needle has precisely overcome these problems. Relying on the principle of negative pressure suction, it achieves efficient and safe collection of liver tissue samples, becoming an indispensable medical needle instrument in the liver disease diagnosis process.
The clinical operation logic of this medical needle is highly scientific. By creating a stable negative pressure at the front end of the needle, it precisely sucks the liver tissue into the needle tube. Combined with its sharp cutting edge, it can quickly cut and completely preserve the tissue sample, achieving single puncture and continuous sampling. This design significantly shortens the puncture operation time. The entire sampling process can be completed in just a few seconds. Compared to traditional biopsy instruments, it greatly reduces the needle's stay time in the liver, effectively lowering the incidence of complications such as liver bleeding and bile duct injury. At the same time, the single-puncture operation mode minimizes the patient's puncture pain and psychological fear, enhancing the patient's compliance with biopsy examinations. It is particularly suitable for elderly and frail liver disease patients who are intolerant to invasive examinations.
In clinical application scenarios, the Menghini liver biopsy needle can meet all types of diagnostic needs for liver diseases. Whether it is the assessment of chronic liver diseases such as viral hepatitis, non-alcoholic fatty liver disease, and liver cirrhosis, or the differential diagnosis of primary, secondary liver cancer, leukemia, and lymphoma involving the liver, it can quickly obtain high-quality histological and cytological samples. The obtained samples have intact structures and high cell viability, which can directly meet the subsequent diagnostic needs such as pathological sections and immunohistochemical testing, effectively avoiding the need for repeated punctures due to unqualified samples, reducing the secondary trauma to patients, and simultaneously improving the clinical diagnostic efficiency and accuracy.
Compared with other types of biopsy medical needles, the clinical suitability of the Menghini liver biopsy needle is more outstanding. Its needle tip design combines sharpness and safety. During the puncture process, it can quickly penetrate the skin and the liver capsule, reducing the tearing and damage to the surrounding tissues; at the same time, it can effectively avoid the large blood vessels and bile ducts in the liver, reducing the risk of intraoperative bleeding. For grassroots medical institutions, this needle has a low operation threshold, no need for complex supporting equipment, and is convenient for medical staff to quickly master the operation skills. It can realize the popularization of liver biopsy technology at the grassroots level and promote the implementation of early screening and diagnosis of liver diseases.
With the increasing incidence of chronic liver diseases year by year, the clinical demand for minimally invasive liver biopsy is continuously growing. The Menghini liver biopsy needle, as the benchmark product among medical needles for diagnostic equipment, has continuously demonstrated its clinical application value. It not only realizes the minimally invasive and convenient upgrade of liver biopsy technology, but also promotes the transformation of liver disease diagnosis from empirical judgment to precise pathological diagnosis, becoming a key link connecting clinical diagnosis and pathological analysis, and providing solid instrument support for the standardized diagnosis and treatment of liver diseases for patients worldwide.
Precision manufacturing technology: The core competitive advantage in the production of medical needles for Menghini liver biopsy needles
Medical needles are precision medical devices. The manufacturing process directly determines the safety and clinical effectiveness of the product. The Menghini liver biopsy needle, as a specialized medical needle for liver diagnosis, has strict requirements for manufacturing precision, material processing, and surface treatment. Each production process must follow the high standards of minimally invasive instruments, thus establishing the core manufacturing barrier for professional biopsy needles.
High-quality raw materials form the foundation of the quality of medical needles. The Menghini liver biopsy needles throughout the production process use medical-grade high-performance metal materials, which possess excellent biocompatibility, mechanical strength, and corrosion resistance. They can fully adapt to the internal environment of the human body and avoid causing adverse reactions such as tissue allergies and inflammations. During the production process, the manufacturer will provide complete material qualification certificates for the bill of materials (BOM) of each product. They control the quality from the source of raw material procurement, ensuring that each batch of materials meets the standards of medical devices and preventing inferior raw materials from flowing into the production process, thus building the first line of defense for product safety.
In the core processing stage, the five-axis laser cutting technology serves as the core support for the precise manufacturing of Menghini liver biopsy needles. This technology belongs to a high-end numerical control processing technique. Compared with traditional cutting equipment, it offers higher processing accuracy and flexibility, enabling precise micro-millimeter-level processing of the needle body and needle tip structure. In response to the special suction structure and sharp needle tip requirements of Menghini liver biopsy needles, the five-axis laser cutting machine can complete complex structure processing from multiple angles and in all directions, precisely controlling the needle tip slope angle, the inner diameter tolerance of the needle tube, and the smoothness of the cutting edge, ensuring that the needle tip is sharp and free of burrs. This not only guarantees the smoothness during puncture but also enables the complete cutting of tissue samples, avoiding problems such as fragmentation and damage to the samples.
The surface treatment process is the key to enhancing the clinical performance of medical needles. The Menghini liver biopsy needle adopts a dual refined processing technology of electrolytic polishing and ultrasonic cleaning. Electrolytic polishing uses the principle of electrochemistry to optimize the smoothness of the inner and outer surfaces of the needle tube, removing tiny burrs, oxide layers and impurities generated during the processing, making the inner wall of the needle tube smooth and unobstructed, ensuring that the tissue samples can smoothly enter the needle tube during negative pressure suction without any blockage or residue; at the same time, it improves the corrosion resistance and biocompatibility of the needle surface, reduces friction with human tissue, and reduces tissue damage during the puncture process.
Ultrasonic cleaning is used as a subsequent purification process. It utilizes high-frequency ultrasonic vibration to thoroughly remove residual metal debris, oil stains, dust and other contaminants inside the needle, achieving deep and seamless cleaning. After undergoing dual treatment, the Menghini liver biopsy needle has a surface roughness that meets the standards, excellent aseptic performance, and fully complies with the hygiene and safety standards for medical needles implanted in the human body. This effectively avoids the risk of postoperative infection caused by inadequate cleaning of the equipment.
In addition, throughout the production process, a meticulous process control system is implemented. From raw material cutting, precise shaping, surface treatment to final assembly, strict quality inspection checkpoints are set up at every stage. Through multiple tests such as size measurement, performance testing, and sealingity testing, the structure, performance, and precision of each needle tip are ensured to meet the design requirements. According to the usage needs of different clinical scenarios, the production process can be flexibly adapted to size adjustments, enabling precise customization of parameters such as needle length and diameter, while balancing product standardization and personalized production.
Precision manufacturing technology is the core competitiveness of the medical needle industry. Menghini liver biopsy needles have achieved a breakthrough by leveraging the triple advantages of high-end processing equipment, refined surface treatment, and full-process quality control. This has overcome the limitations of traditional biopsy needles and upgraded both the performance and safety of the products. It has also set an industry benchmark for the production of high-end medical diagnostic needles, driving the medical needle manufacturing industry towards higher precision, higher quality, and higher safety.